1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA CTRPv2 pan-cancer AAC 0.17 3e-06
mRNA CCLE pan-cancer AAC 0.24 6e-06
mRNA CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA CCLE pan-cancer AAC 0.21 3e-05
mRNA CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA CCLE pan-cancer AAC 0.19 9e-05
Download CSV